as on October 24, 2025 at 1:29 am IST
Day's High
19.05%
Upside
52 Week's Low
52 Week's High
50.18%
Downside
338.10%
Upside
Check Sutro Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$98.3M
EPS (TTM)
-1.03
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.98
Industry PE ratio
-0.8798722044728434
PEG Ratio
0EBITDA
-158.1M
Revenue (TTM)
104.5M
Profit Margin
-199.76%
Return On Equity TTM
-347.64%
Track how Sutro Biopharma Inc P/E has moved over time to understand its valuation trends.
Sutro Biopharma Inc in the last 5 years
Lowest (-10.75x)
June 30, 2021
Today (-2.98x)
October 24, 2025
Industry (-0.88x)
October 24, 2025
Highest (-0.37x)
June 30, 2025
Today’s Price to Earnings Ratio: -2.98x
Compare market cap, revenue, PE, and other key metrics of Sutro Biopharma Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $98.3M | -91.38% | -2.98 | -199.76% | |
| BUY | $60.9B | 251.94% | -505.15 | -12.96% | |
| NA | $35.9B | NA | NA | -3.89% | |
| BUY | $109.3B | 99.75% | 30.31 | 31.86% | |
| BUY | $62.0B | -0.71% | 14.73 | 31.37% |
The Sutro Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sutro Biopharma Inc investment value today
Current value as on today
₹34,909
Returns
Returns from Sutro Biopharma Inc Stock
Dollar Returns*
₹4,562 (+4.56%)
Based on 16 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Sutro Biopharma Inc. Average target price of $2.69
Get share price movements and forecasts by analysts on Sutro Biopharma Inc.
What analysts predicted
60.97%UPSIDE
Target Price
$2.69
Current Price
$1.05
Analyzed by
16 Analysts
Target
$2.69
Sutro Biopharma Inc target price $2.69, a slight upside of 60.97% compared to current price of $1.05. According to 16 analysts rating.
Search interest for Sutro Biopharma Inc Stock has increased by 273% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:273% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -75.96M → -11.49M (in $), with an average increase of 560.7% per quarter
Revenue Rich
![]()
Revenue is up for the last 4 quarters, 8.52M → 63.74M (in $), with an average increase of 43.4% per quarter
Price Rise
![]()
In the last 1 month, STRO stock has moved up by 20.9%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.0% return, outperforming this stock by 127.4%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 136.9% return, outperforming this stock by 220.5%
| Organisation | Sutro Biopharma Inc |
| Headquarters | 111 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
| Industry | Health Technology |
| CEO | Ms. Jane Chung R.Ph. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Jane Chung R.Ph. | CEO & Director |
Mr. Edward C. Albini M.B.A | Secretary |
Mr. Gregory K. Chow BA, CPA, MBA | Chief Financial Officer |
Dr. Venkatesh Srinivasan Ph.d. | Chief Technical Operations Officer |
Dr. Hans-Peter Gerber Ph.D. | Chief Scientific Officer |
Dr. James R. Swartz DSc, Ph.D., Sc.D. | Founder |
Mr. David Pauling J.D., M.A. | Chief Administrative Officer & General Counsel |
Dr. Barbara Leyman Ph.D. | Chief Business Officer |
Ms. Regina Cheng | Vice President & Controller |
Sutro Biopharma Inc share price today is $1.05 as on at the close of the market. Sutro Biopharma Inc share today touched a day high of $1.25 and a low of $1.05.
Sutro Biopharma Inc share touched a 52 week high of $4.6 on and a 52 week low of $0.52 on . Sutro Biopharma Inc stock price today i.e. is closed at $1.05,which is 77.17% down from its 52 week high and 100.73% up from its 52 week low.
Sutro Biopharma Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Sutro Biopharma Inc (STRO) shares with as little as ₹87.759 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.59 in Sutro Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sutro Biopharma Inc share’s latest price of $1.05 as on October 24, 2025 at 1:29 am IST, you will get 9.5238 shares of Sutro Biopharma Inc. Learn more about
fractional shares .
Sutro Biopharma Inc stock has given -91.38% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?